img

Global Zonisamide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Zonisamide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Zonisamide is a medication used to treat the symptoms of epilepsy and Parkinson's disease.
Zonisamide report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Zonisamide market is projected to reach US$ 718.8 million in 2029, increasing from US$ 489 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2029. Demand from Adult and Pediatric are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Zonisamide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Zonisamide key manufacturers include Concordia, Eisai, Zydus Pharmaceuticals, Sun Pharma, Wockhardt, Mylan, APOTEX, Teva and Glenmark, etc. Concordia, Eisai, Zydus Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Zonisamide can be divided into 25mg, 50mg and 100mg,, etc. 25mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Zonisamide is widely used in various fields, such as Adult, Pediatric and Geriatric,, etc. Adult provides greatest supports to the Zonisamide industry development. In 2022, global % sales of Zonisamide went into Adult filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Zonisamide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Concordia
Eisai
Zydus Pharmaceuticals
Sun Pharma
Wockhardt
Mylan
APOTEX
Teva
Glenmark
Bluepharma
Invagen Pharmaceuticals
Intas Pharmaceuticals
Segment by Type
25mg
50mg
100mg

Segment by Application


Adult
Pediatric
Geriatric

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Zonisamide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Zonisamide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Zonisamide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Zonisamide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Zonisamide introduction, etc. Zonisamide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Zonisamide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Zonisamide Market Overview
1.1 Zonisamide Product Overview
1.2 Zonisamide Market Segment by Type
1.2.1 25mg
1.2.2 50mg
1.2.3 100mg
1.3 Global Zonisamide Market Size by Type
1.3.1 Global Zonisamide Market Size Overview by Type (2018-2029)
1.3.2 Global Zonisamide Historic Market Size Review by Type (2018-2024)
1.3.3 Global Zonisamide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Zonisamide Sales Breakdown by Type (2018-2024)
1.4.2 Europe Zonisamide Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Zonisamide Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Zonisamide Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Zonisamide Sales Breakdown by Type (2018-2024)
2 Global Zonisamide Market Competition by Company
2.1 Global Top Players by Zonisamide Sales (2018-2024)
2.2 Global Top Players by Zonisamide Revenue (2018-2024)
2.3 Global Top Players by Zonisamide Price (2018-2024)
2.4 Global Top Manufacturers Zonisamide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Zonisamide Market Competitive Situation and Trends
2.5.1 Zonisamide Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Zonisamide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zonisamide as of 2022)
2.7 Date of Key Manufacturers Enter into Zonisamide Market
2.8 Key Manufacturers Zonisamide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Zonisamide Status and Outlook by Region
3.1 Global Zonisamide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Zonisamide Historic Market Size by Region
3.2.1 Global Zonisamide Sales in Volume by Region (2018-2024)
3.2.2 Global Zonisamide Sales in Value by Region (2018-2024)
3.2.3 Global Zonisamide Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Zonisamide Forecasted Market Size by Region
3.3.1 Global Zonisamide Sales in Volume by Region (2024-2029)
3.3.2 Global Zonisamide Sales in Value by Region (2024-2029)
3.3.3 Global Zonisamide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Zonisamide by Application
4.1 Zonisamide Market Segment by Application
4.1.1 Adult
4.1.2 Pediatric
4.1.3 Geriatric
4.2 Global Zonisamide Market Size by Application
4.2.1 Global Zonisamide Market Size Overview by Application (2018-2029)
4.2.2 Global Zonisamide Historic Market Size Review by Application (2018-2024)
4.2.3 Global Zonisamide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Zonisamide Sales Breakdown by Application (2018-2024)
4.3.2 Europe Zonisamide Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Zonisamide Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Zonisamide Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Zonisamide Sales Breakdown by Application (2018-2024)
5 North America Zonisamide by Country
5.1 North America Zonisamide Historic Market Size by Country
5.1.1 North America Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Zonisamide Sales in Volume by Country (2018-2024)
5.1.3 North America Zonisamide Sales in Value by Country (2018-2024)
5.2 North America Zonisamide Forecasted Market Size by Country
5.2.1 North America Zonisamide Sales in Volume by Country (2024-2029)
5.2.2 North America Zonisamide Sales in Value by Country (2024-2029)
6 Europe Zonisamide by Country
6.1 Europe Zonisamide Historic Market Size by Country
6.1.1 Europe Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Zonisamide Sales in Volume by Country (2018-2024)
6.1.3 Europe Zonisamide Sales in Value by Country (2018-2024)
6.2 Europe Zonisamide Forecasted Market Size by Country
6.2.1 Europe Zonisamide Sales in Volume by Country (2024-2029)
6.2.2 Europe Zonisamide Sales in Value by Country (2024-2029)
7 Asia-Pacific Zonisamide by Region
7.1 Asia-Pacific Zonisamide Historic Market Size by Region
7.1.1 Asia-Pacific Zonisamide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Zonisamide Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Zonisamide Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Zonisamide Forecasted Market Size by Region
7.2.1 Asia-Pacific Zonisamide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Zonisamide Sales in Value by Region (2024-2029)
8 Latin America Zonisamide by Country
8.1 Latin America Zonisamide Historic Market Size by Country
8.1.1 Latin America Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Zonisamide Sales in Volume by Country (2018-2024)
8.1.3 Latin America Zonisamide Sales in Value by Country (2018-2024)
8.2 Latin America Zonisamide Forecasted Market Size by Country
8.2.1 Latin America Zonisamide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Zonisamide Sales in Value by Country (2024-2029)
9 Middle East and Africa Zonisamide by Country
9.1 Middle East and Africa Zonisamide Historic Market Size by Country
9.1.1 Middle East and Africa Zonisamide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Zonisamide Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Zonisamide Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Zonisamide Forecasted Market Size by Country
9.2.1 Middle East and Africa Zonisamide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Zonisamide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Concordia
10.1.1 Concordia Company Information
10.1.2 Concordia Introduction and Business Overview
10.1.3 Concordia Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Concordia Zonisamide Products Offered
10.1.5 Concordia Recent Development
10.2 Eisai
10.2.1 Eisai Company Information
10.2.2 Eisai Introduction and Business Overview
10.2.3 Eisai Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Eisai Zonisamide Products Offered
10.2.5 Eisai Recent Development
10.3 Zydus Pharmaceuticals
10.3.1 Zydus Pharmaceuticals Company Information
10.3.2 Zydus Pharmaceuticals Introduction and Business Overview
10.3.3 Zydus Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Zydus Pharmaceuticals Zonisamide Products Offered
10.3.5 Zydus Pharmaceuticals Recent Development
10.4 Sun Pharma
10.4.1 Sun Pharma Company Information
10.4.2 Sun Pharma Introduction and Business Overview
10.4.3 Sun Pharma Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sun Pharma Zonisamide Products Offered
10.4.5 Sun Pharma Recent Development
10.5 Wockhardt
10.5.1 Wockhardt Company Information
10.5.2 Wockhardt Introduction and Business Overview
10.5.3 Wockhardt Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Wockhardt Zonisamide Products Offered
10.5.5 Wockhardt Recent Development
10.6 Mylan
10.6.1 Mylan Company Information
10.6.2 Mylan Introduction and Business Overview
10.6.3 Mylan Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Mylan Zonisamide Products Offered
10.6.5 Mylan Recent Development
10.7 APOTEX
10.7.1 APOTEX Company Information
10.7.2 APOTEX Introduction and Business Overview
10.7.3 APOTEX Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.7.4 APOTEX Zonisamide Products Offered
10.7.5 APOTEX Recent Development
10.8 Teva
10.8.1 Teva Company Information
10.8.2 Teva Introduction and Business Overview
10.8.3 Teva Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Teva Zonisamide Products Offered
10.8.5 Teva Recent Development
10.9 Glenmark
10.9.1 Glenmark Company Information
10.9.2 Glenmark Introduction and Business Overview
10.9.3 Glenmark Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Glenmark Zonisamide Products Offered
10.9.5 Glenmark Recent Development
10.10 Bluepharma
10.10.1 Bluepharma Company Information
10.10.2 Bluepharma Introduction and Business Overview
10.10.3 Bluepharma Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bluepharma Zonisamide Products Offered
10.10.5 Bluepharma Recent Development
10.11 Invagen Pharmaceuticals
10.11.1 Invagen Pharmaceuticals Company Information
10.11.2 Invagen Pharmaceuticals Introduction and Business Overview
10.11.3 Invagen Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Invagen Pharmaceuticals Zonisamide Products Offered
10.11.5 Invagen Pharmaceuticals Recent Development
10.12 Intas Pharmaceuticals
10.12.1 Intas Pharmaceuticals Company Information
10.12.2 Intas Pharmaceuticals Introduction and Business Overview
10.12.3 Intas Pharmaceuticals Zonisamide Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Intas Pharmaceuticals Zonisamide Products Offered
10.12.5 Intas Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Zonisamide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Zonisamide Industrial Chain Analysis
11.4 Zonisamide Market Dynamics
11.4.1 Zonisamide Industry Trends
11.4.2 Zonisamide Market Drivers
11.4.3 Zonisamide Market Challenges
11.4.4 Zonisamide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Zonisamide Distributors
12.3 Zonisamide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 25mg
Table 2. Major Company of 50mg
Table 3. Major Company of 100mg
Table 4. Global Zonisamide Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Zonisamide Sales by Type (2018-2024) & (K Units)
Table 6. Global Zonisamide Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Zonisamide Sales by Type (2018-2024) & (US& Million)
Table 8. Global Zonisamide Market Share in Value by Type (2018-2024)
Table 9. Global Zonisamide Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Zonisamide Sales by Type (2024-2029) & (K Units)
Table 11. Global Zonisamide Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Zonisamide Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Zonisamide Sales Market Share in Value by Type (2024-2029)
Table 14. Global Zonisamide Price by Type (2024-2029) & (USD/Unit)
Table 15. North America Zonisamide Sales by Type (2018-2024) & (K Units)
Table 16. North America Zonisamide Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Zonisamide Sales (K Units) by Type (2018-2024)
Table 18. Europe Zonisamide Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Zonisamide Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Zonisamide Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Zonisamide Sales (K Units) by Type (2018-2024)
Table 22. Latin America Zonisamide Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Zonisamide Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Zonisamide Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Zonisamide Sales by Company (2018-2024) & (K Units)
Table 26. Global Zonisamide Sales Share by Company (2018-2024)
Table 27. Global Zonisamide Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Zonisamide Revenue Share by Company (2018-2024)
Table 29. Global Market Zonisamide Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Zonisamide Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Zonisamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zonisamide as of 2022)
Table 33. Date of Key Manufacturers Enter into Zonisamide Market
Table 34. Key Manufacturers Zonisamide Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Zonisamide Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Zonisamide Sales by Region (2018-2024) & (K Units)
Table 38. Global Zonisamide Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Zonisamide Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Zonisamide Sales Market Share in Value by Region (2018-2024)
Table 41. Global Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Zonisamide Sales by Region (2024-2029) & (K Units)
Table 43. Global Zonisamide Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Zonisamide Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Zonisamide Sales Market Share in Value by Region (2024-2029)
Table 46. Global Zonisamide Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 47. Global Zonisamide Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Zonisamide Sales by Application (2018-2024) & (K Units)
Table 49. Global Zonisamide Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Zonisamide Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Zonisamide Sales Market Share in Value by Application (2018-2024)
Table 52. Global Zonisamide Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Zonisamide Sales by Application (2024-2029) & (K Units)
Table 54. Global Zonisamide Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Zonisamide Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Zonisamide Sales Market Share in Value by Application (2024-2029)
Table 57. Global Zonisamide Price by Application (2024-2029) & (USD/Unit)
Table 58. North America Zonisamide Sales by Application (2018-2024) (K Units)
Table 59. North America Zonisamide Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Zonisamide Sales by Application (2018-2024) (K Units)
Table 61. Europe Zonisamide Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Zonisamide Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Zonisamide Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Zonisamide Sales by Application (2018-2024) (K Units)
Table 65. Latin America Zonisamide Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Zonisamide Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Zonisamide Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Zonisamide Sales by Country (2018-2024) & (K Units)
Table 69. North America Zonisamide Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Zonisamide Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Zonisamide Sales Market Share in Value by Country (2018-2024)
Table 72. North America Zonisamide Sales by Country (2024-2029) & (K Units)
Table 73. North America Zonisamide Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Zonisamide Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Zonisamide Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Zonisamide Sales by Country (2018-2024) & (K Units)
Table 77. Europe Zonisamide Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Zonisamide Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Zonisamide Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Zonisamide Sales by Country (2024-2029) & (K Units)
Table 81. Europe Zonisamide Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Zonisamide Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Zonisamide Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Zonisamide Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Zonisamide Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Zonisamide Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Zonisamide Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Zonisamide Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Zonisamide Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Zonisamide Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Zonisamide Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Zonisamide Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Zonisamide Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Zonisamide Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Zonisamide Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Zonisamide Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Zonisamide Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Zonisamide Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Zonisamide Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Zonisamide Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Zonisamide Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Zonisamide Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Zonisamide Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Zonisamide Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Zonisamide Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Zonisamide Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Zonisamide Sales Market Share in Value by Country (2024-2029)
Table 108. Concordia Company Information
Table 109. Concordia Introduction and Business Overview
Table 110. Concordia Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Concordia Zonisamide Product
Table 112. Concordia Recent Development
Table 113. Eisai Company Information
Table 114. Eisai Introduction and Business Overview
Table 115. Eisai Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Eisai Zonisamide Product
Table 117. Eisai Recent Development
Table 118. Zydus Pharmaceuticals Company Information
Table 119. Zydus Pharmaceuticals Introduction and Business Overview
Table 120. Zydus Pharmaceuticals Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Zydus Pharmaceuticals Zonisamide Product
Table 122. Zydus Pharmaceuticals Recent Development
Table 123. Sun Pharma Company Information
Table 124. Sun Pharma Introduction and Business Overview
Table 125. Sun Pharma Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Sun Pharma Zonisamide Product
Table 127. Sun Pharma Recent Development
Table 128. Wockhardt Company Information
Table 129. Wockhardt Introduction and Business Overview
Table 130. Wockhardt Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Wockhardt Zonisamide Product
Table 132. Wockhardt Recent Development
Table 133. Mylan Company Information
Table 134. Mylan Introduction and Business Overview
Table 135. Mylan Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Mylan Zonisamide Product
Table 137. Mylan Recent Development
Table 138. APOTEX Company Information
Table 139. APOTEX Introduction and Business Overview
Table 140. APOTEX Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. APOTEX Zonisamide Product
Table 142. APOTEX Recent Development
Table 143. Teva Company Information
Table 144. Teva Introduction and Business Overview
Table 145. Teva Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Teva Zonisamide Product
Table 147. Teva Recent Development
Table 148. Glenmark Company Information
Table 149. Glenmark Introduction and Business Overview
Table 150. Glenmark Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Glenmark Zonisamide Product
Table 152. Glenmark Recent Development
Table 153. Bluepharma Company Information
Table 154. Bluepharma Introduction and Business Overview
Table 155. Bluepharma Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Bluepharma Zonisamide Product
Table 157. Bluepharma Recent Development
Table 158. Invagen Pharmaceuticals Company Information
Table 159. Invagen Pharmaceuticals Introduction and Business Overview
Table 160. Invagen Pharmaceuticals Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Invagen Pharmaceuticals Zonisamide Product
Table 162. Invagen Pharmaceuticals Recent Development
Table 163. Intas Pharmaceuticals Company Information
Table 164. Intas Pharmaceuticals Introduction and Business Overview
Table 165. Intas Pharmaceuticals Zonisamide Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Intas Pharmaceuticals Zonisamide Product
Table 167. Intas Pharmaceuticals Recent Development
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Zonisamide Market Trends
Table 171. Zonisamide Market Drivers
Table 172. Zonisamide Market Challenges
Table 173. Zonisamide Market Restraints
Table 174. Zonisamide Distributors List
Table 175. Zonisamide Downstream Customers
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Zonisamide Product Picture
Figure 2. Global Zonisamide Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Zonisamide Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Zonisamide Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 25mg
Figure 6. Global 25mg Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 50mg
Figure 8. Global 50mg Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 100mg
Figure 10. Global 100mg Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Zonisamide Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Zonisamide Sales Market Share by Type in 2022 & 2029
Figure 13. North America Zonisamide Sales Market Share in Volume by Type in 2022
Figure 14. North America Zonisamide Sales Market Share in Value by Type in 2022
Figure 15. Europe Zonisamide Sales Market Share in Volume by Type in 2022
Figure 16. Europe Zonisamide Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Zonisamide Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Zonisamide Sales Market Share in Value by Type in 2022
Figure 19. Latin America Zonisamide Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Zonisamide Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Zonisamide Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Zonisamide Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Zonisamide Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Zonisamide Revenue in 2022
Figure 25. Zonisamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Adult
Figure 27. Global Adult Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Pediatric
Figure 29. Global Pediatric Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Geriatric
Figure 31. Global Geriatric Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Zonisamide Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Zonisamide Sales Market Share by Application in 2022 & 2029
Figure 34. North America Zonisamide Sales Market Share in Volume by Application in 2022
Figure 35. North America Zonisamide Sales Market Share in Value by Application in 2022
Figure 36. Europe Zonisamide Sales Market Share in Volume by Application in 2022
Figure 37. Europe Zonisamide Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Zonisamide Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Zonisamide Sales Market Share in Value by Application in 2022
Figure 40. Latin America Zonisamide Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Zonisamide Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Zonisamide Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Zonisamide Manufacturing Cost Structure
Figure 45. Zonisamide Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries